Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 1c

Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.71 million versus the consensus estimate of $0 .

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.

You May Also Be Interested In

• Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
• Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
• loanDepot receives NYSE non-compliance notice over stock price